"Funding for BioWatch, an early warning system to detect deadly pathogens in 30 U.S. cities, may be in jeopardy after cost estimates surged to $5.7 billion, six times the initial assessment."
The costs seemed to have escalated rapidly over the past several years. Is this still a good investment in risk management?